KOLTERMAN; Orville G.
Patent Applications and Registrations
Patent applications and USPTO patent grants for KOLTERMAN; Orville G..The latest application filed is for "methods and compositions for treatment of microbiome-associated disorders".
- KOLTERMAN; Orville G. - La Jolla CA
- Kolterman; Orville G. - Poway CA
- KOLTERMAN; Orville G. - San Diego CA
- KOLTERMAN, ORVILLE G - POWAY CA
| Patent | Date |
|---|---|
| Methods And Compositions For Treatment Of Microbiome-associated Disorders App 20200268811 - CUTCLIFFE; Colleen ; et al. | 2020-08-27 |
| Methods And Compositions Relating To Isolated And Purified Microbes App 20200121738 - CUTCLIFFE; Colleen ; et al. | 2020-04-23 |
| Insulin-pramlintide Compositions And Methods For Making And Using Them App 20150174209 - Chiquette; Elaine ; et al. | 2015-06-25 |
| Formulations and Uses of Exendins and Exendin Agonist Analogs App 20150080308 - KOLTERMAN; Orville G. ; et al. | 2015-03-19 |
| Formulations of Exendins and Exendin Agonist Analogs App 20130165379 - Kolterman; Orville G. ; et al. | 2013-06-27 |
| Amylin Family Peptides and Methods for Making and Using Them App 20120196799 - DUFT; Bradford J. ; et al. | 2012-08-02 |
| Methods for Lowering Plasma Glucagon with Exendins and Exendin Agonist Analogs App 20110281798 - KOLTERMAN; Orville G. ; et al. | 2011-11-17 |
| Methods for treating obesity Grant 7,910,548 - Duft , et al. March 22, 2 | 2011-03-22 |
| Lyophilized formulations of exendins and exendin agonist analogs Grant 7,906,146 - Kolterman , et al. March 15, 2 | 2011-03-15 |
| Lyophilized Formulations of Exendins and Exendin Agonist Analogs App 20090215694 - Kolterman; Orville G. ; et al. | 2009-08-27 |
| Exendin Analog Formulations App 20080249018 - KOLTERMAN; Orville G. ; et al. | 2008-10-09 |
| Methods for regulating postprandial blood glucose Grant 7,407,934 - Kolterman , et al. August 5, 2 | 2008-08-05 |
| Exendin analog formulations Grant 7,399,489 - Kolterman , et al. July 15, 2 | 2008-07-15 |
| Novel exendin agonist formulations and methods of administration thereof App 20060183677 - Young; AndrewA ; et al. | 2006-08-17 |
| Exendin analog formulations App 20060069029 - Kolterman; Orville G. ; et al. | 2006-03-30 |
| Exendin agonist formulations and methods of administration thereof Grant 6,902,744 - Kolterman , et al. June 7, 2 | 2005-06-07 |
| Methods for regulating gastrointestinal motility App 20040097415 - Kolterman, Orville G. ; et al. | 2004-05-20 |
| Methods For Treating Obesity App 20040022807 - DUFT, BRADFORD J ; et al. | 2004-02-05 |
| Methods for regulating gastrointestinal motility Grant 6,608,029 - Kolterman , et al. August 19, 2 | 2003-08-19 |
| Use of amylin agonists to modulate triglycerides App 20030130177 - Kolterman, Orville G. ; et al. | 2003-07-10 |
| Novel exendin agonist formulations and methods of administration thereof App 20030087820 - Young, Andrew A. ; et al. | 2003-05-08 |
| Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia App 20030036504 - Kolterman, Orville G. ; et al. | 2003-02-20 |
| Methods For Treating Obesity App 20030026812 - DUFT, BRADFORD J. ; et al. | 2003-02-06 |
| Treatment of type II diabetes mellitus with amylin agonists Grant 6,417,164 - Kolterman , et al. July 9, 2 | 2002-07-09 |
| Treatment of Type II diabetes mellutis with amylin agonists Grant 6,143,718 - Kolterman , et al. November 7, 2 | 2000-11-07 |
| Methods for regulating gastrointestinal motility Grant 6,114,304 - Kolterman , et al. September 5, 2 | 2000-09-05 |
| Methods for regulating gastrointestinal motility Grant 5,795,861 - Kolterman , et al. August 18, 1 | 1998-08-18 |
| SEC | 0001236394 | KOLTERMAN ORVILLE G |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 